Normoftal

Eye Research only Preliminary

Also called Normophthal

A short peptide from the Russian (Khavinson) bioregulator family associated with eye and retinal tissue. The name appears in the literature as a synonym for the Lys-Glu dipeptide, the same structure as Vilon. The source catalog lists it under peptides and gives no description.

Evidence at a glance

Evidence
Preliminary — Very little published work
Status
Research compound only
Dosing
No human study has set a dose

Almost no published data, and the name overlaps with the Lys-Glu dipeptide (Vilon). Treat as unconfirmed.

What studies report

How it works

Not established. It is described as a short peptide associated with retinal tissue, but there is almost nothing published on how it is supposed to act.

Binds a receptor on the cell surface and signals inward

Where it acts

Eyes

The library groups this compound under Eye. The diagram shows that target, not every tissue it reaches.

Illustrated

A cutaway of a human eyeball showing cornea, iris, lens, vitreous chamber, retina lining the back and optic nerve, accurate relative arrangement.

AI-generated subject illustration; not a depiction of the compound or evidence of its effects.

Why people take it

Eye and retinal support

Reasons people seek it out — not a list of proven effects.

Status: Very little published data. Treat details as unconfirmed.

Route
Subcutaneous injection, from reconstituted lyophilised powder
Available as
20 mg

Search PubMed for Normoftal → We link a live search rather than a fixed citation list, so it stays current and nothing here is a reference we have not checked.

Educational information only. Nothing here is medical advice, a dosing protocol, or a recommendation to use any compound. Most entries describe substances not approved for human use. Talk to a licensed clinician before acting on anything you read here. How to read these entries.